Search results for: Pricing and Reimbursement
Filter search results
OHE Involved in Developing New AMS Report on Stratified Medicines
15 July 2013
…personalised medicine. The pricing and reimbursement recommendations included in the report include the following. Introducing flexible pricing for drugs and prices reflective of value for diagnostics. This is to address…
Our Contributions to the Economics of Personalised Medicine
7 March 2018
…pricing and market access agreements This strand of research considers various pricing strategies to incentivise the R&D of personalised medicines and increase their uptake. This includes incentivising combination therapies…
Dilek Sernur Eminoğulları
26 January 2024
…policy formulation regarding pharmaceutical reimbursement, economic evaluation of drugs applying for reimbursement, drafting alternative reimbursement agreements, analysis of innovative pharmaceutical pricing and reimbursement models. She took active role in the…
Exploring the Financial Sustainability of Gene Therapies
5 January 2021
…Towse, A., Graf von der Schulenburg, J.M. and Wong, O. 2018. Advanced Therapy Medicinal Products and Health Technology Assessment Principles and Practices for Value-based and Sustainable Healthcare, T he European…
2024 Innovation Policy Prize
…of health and sustainability. As co-chair of the Joint Society for Medical Decision Making (SMDM) and International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Task Force on Modelling Methods, Andrew…
2022 Innovation Policy Prize
2022 Winner and Finalists We are delighted to present the winner and finalists of the OHE Innovation Policy Prize 2022. Our four finalists have competed to create the most innovative, sustainable, and global solution for…
Value Based Pricing in Sweden: Lessons for Design?
28 November 2012
…made extensive use of coverage with evidence development to allow reimbursement for orphan drugs and approved all but one of the 30 applications for reimbursement received between 2003 and 2010….
Key Considerations for Early Access Schemes for Single-Administration (One-Time) Therapies
1 June 2021
…where the benefits are judged to be greater than the risks. Following regulatory approval, there are different national pricing and reimbursement processes, which in most cases, must conclude before patients…
Differential Pricing – A Win-Win Solution?
2 March 2011
Summarised in this post is a just-released OHE Occasional Paper that examines the potentially positive impact of differential pricing in Europe and the overall negative effects of international reference pricing…